---
layout: post
title: "午间公告：安科生物人生长激素注射液申请获批"
date: 2021-12-30 12:06:29 +0800
categories: emnews
tags: 东财滚动新闻
---
> 安科生物：人生长激素注射液获药品补充申请批准通知书；恩华药业：注射用盐酸瑞芬太尼增加适应症获得药物临床试验批准通知书；兴瑞科技：拟以评估价格831万元向关联方慈溪骏瑞购买工业房地产。（证券时报网）

<p><span id="stock_0.300009"><a href="http://quote.eastmoney.com/unify/r/0.300009" class="keytip" data-code="0,300009">安科生物</a></span><span id="quote_0.300009"></span>：人生长激素注射液获药品补充申请批准通知书；<span id="stock_0.002262"><a href="http://quote.eastmoney.com/unify/r/0.002262" class="keytip" data-code="0,002262">恩华药业</a></span><span id="quote_0.002262"></span>：注射用盐酸瑞芬太尼增加适应症获得药物临床试验批准通知书；<span id="stock_0.002937"><a href="http://quote.eastmoney.com/unify/r/0.002937" class="keytip" data-code="0,002937">兴瑞科技</a></span><span id="quote_0.002937"></span>：拟以评估价格831万元向关联方慈溪骏瑞购买工业房地产。</p><p class="em_media">（文章来源：<span id="bk_90.BK0473"><a href="http://quote.eastmoney.com/unify/r/90.BK0473" class="keytip" data-code="90,BK0473">证券</a></span><span id="bkquote_90.BK0473"></span>时报网）</p>

<http://finance.eastmoney.com/news/1354,202112302231270080.html>

[返回东财滚动新闻](//finews.withounder.com/emnews/)｜[返回首页](//finews.withounder.com/)